(Q36682815)

English

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer

scientific article published on March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

radiation oncology

1 reference

based on heuristic

inferred from title

12

object named as

Monica Morrow

1 reference

Europe PubMed Central

15 August 2017

PMC publication ID

Mariana Chavez-MacGregor

8

object named as

Mariana Chavez-MacGregor

1 reference

Europe PubMed Central

15 August 2017

PMC publication ID

Nehmat Houssami

10

object named as

Nehmat Houssami

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Meena S Moran

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Stuart J Schnitt

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Armando E Giuliano

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jay R Harris

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Seema A Khan

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Janet Horton

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Suzanne Klimberg

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Gary Freedman

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Peggy L Johnson

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 March 2014

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

88

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

553-564

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Breast-conserving therapy for triple-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Breast conservation therapy: the influence of molecular subtype and margins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Triple-negative breast cancer is not a contraindication for breast conservation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Surgeon recommendations and receipt of mastectomy for treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Hormonal therapies for early breast cancer: systematic review and economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

30 September 2017

Breast cancer subtypes and the risk of local and regional relapse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

Optimal surgical treatment of invasive lobular carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

28 June 2018

Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Variability in reexcision following breast conservation surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Long-term results of hypofractionated radiation therapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

5 September 2018

Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

20 October 2018

Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

4 December 2018

Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4790083

4 December 2018

The relationship between shaved margin and inked margin status in breast excision specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prone vs supine positioning for breast cancer radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management factors contribute to the decision for contralateral prophylactic mastectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Margins of "lumpectomy" for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France

1 reference

https://pubmed.ncbi.nlm.nih.gov/24521674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2013.11.012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36682815&oldid=1531767803"